%0 Journal Article
%T Semiquantitative assessment of phosphatase and tensin homolog value with immunohistochemistry in colorectal cancer.
%A Jeo WS
%A Lalisang TJM
%A Siregar NC
%A Sudoyo AW
%A Pakasi T
%A Jusman SW
%A Asmarinah A
%J Int J Biol Markers
%V 0
%N 0
%D 2024 Aug 9
%M 39118563
%F 3.248
%R 10.1177/03936155241265346
%X <B>BACKGROUND: </B>Colorectal cancer has emerged as a concerning health problem, ranking the third most common form of cancer in both men and women. The phosphatase and tensin homologue (PTEN) protein is widely known for its role as an inhibitor of the phosphatidylinositol 3-kinase/protein kinase-B/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway, playing a major role inhibiting tumor development. Previous studies investigated the role of this protein in the PI3K pathway and how it affected colorectal cancer. However, a standardized cut-off value for PTEN expression has not been established.<BR><B>METHODS: </B>Immunohistochemistry was used in examining PTEN. The staining grade ranging from 0 to 3 was then multiplied by the number of 100 cancer cells counted, with total score between 0 and 300. In this study, receiver operating characteristic (ROC) curve was employed to determine the expression cut-off value for PTEN in colorectal cancer.<BR><B>RESULTS: </B>This study showed statistically significant results (P < 0.001) in either tumor or non-tumor tissues by using the ROC curve with a cut-off value of 199.0. This study also revealed significant correlation between nodal status with PTEN (P = 0.008) and stage with PTEN (P = 0.019) with sensitivity 0.753 and specificity 0.728.<BR><B>CONCLUSIONS: </B>Semiquantitative assessment with cell counting multiplied by color intensity is a good method in determining PTEN expression. The use of immunohistochemical staining intensity and cell scoring with ROC cut-off is effective to elaborate the effects of PTEN in colorectal cancer (PTEN value > 199.0 was classified as strong and ≤ 199.0 as weak).